These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27043038)

  • 1. Plasma-derived exosomes in acute myeloid leukemia for detection of minimal residual disease: are we ready?
    Boyiadzis M; Whiteside TL
    Expert Rev Mol Diagn; 2016 Jun; 16(6):623-9. PubMed ID: 27043038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.
    Hornick NI; Huan J; Doron B; Goloviznina NA; Lapidus J; Chang BH; Kurre P
    Sci Rep; 2015 Jun; 5():11295. PubMed ID: 26067326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.
    Lin X; Ling Q; Lv Y; Ye W; Huang J; Li X; Guo Q; Wang J; Li Z; Jin J
    Cancer Biomark; 2020; 28(2):151-158. PubMed ID: 32176633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and potential of exosome analysis for early pancreatic cancer detection.
    Erb U; Zöller M
    Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of Biologically Active Exosomes from Plasma of Patients with Cancer.
    Hong CS; Funk S; Whiteside TL
    Methods Mol Biol; 2017; 1633():257-265. PubMed ID: 28735492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.
    Hong CS; Muller L; Boyiadzis M; Whiteside TL
    PLoS One; 2014; 9(8):e103310. PubMed ID: 25093329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches.
    Zarovni N; Corrado A; Guazzi P; Zocco D; Lari E; Radano G; Muhhina J; Fondelli C; Gavrilova J; Chiesi A
    Methods; 2015 Oct; 87():46-58. PubMed ID: 26044649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-plasmonic exosome diagnostics.
    Im H; Shao H; Weissleder R; Castro CM; Lee H
    Expert Rev Mol Diagn; 2015 Jun; 15(6):725-33. PubMed ID: 25936957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal biomarkers for cancer diagnosis and patient monitoring.
    Makler A; Asghar W
    Expert Rev Mol Diagn; 2020 Apr; 20(4):387-400. PubMed ID: 32067543
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential of tumor-derived exosomes for noninvasive cancer monitoring.
    Whiteside TL
    Expert Rev Mol Diagn; 2015; 15(10):1293-310. PubMed ID: 26289602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
    Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
    Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP; Kerin MJ; Dwyer RM
    Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection.
    Bernardi S; Farina M; Bosio K; Di Lucanardo A; Leoni A; Re F; Polverelli N; Turra A; Morello E; Accorsi Buttini E; Zollner T; Bonvicini C; Malagola M; Russo D
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome: An Emerging Source of Biomarkers for Human Diseases.
    Xu L; Wu LF; Deng FY
    Curr Mol Med; 2019; 19(6):387-394. PubMed ID: 31288712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in acute myelogenous leukemia.
    Raanani P; Ben-Bassat I
    Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging roles of exosomes in leukemogeneis.
    Zhou J; Wang S; Sun K; Chng WJ
    Oncotarget; 2016 Aug; 7(31):50698-50707. PubMed ID: 27191983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of exosomal proteins in cancer diagnosis.
    Li W; Li C; Zhou T; Liu X; Liu X; Li X; Chen D
    Mol Cancer; 2017 Aug; 16(1):145. PubMed ID: 28851367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
    Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.